Reinsurer

A reinsurer is an insurance company that provides coverage to other insurance companies, known as ceding companies, to help manage their risks. Reinsurers essentially insure the risk that the ceding company has taken on, which helps the ceding company to spread its risk and stabilize its underwriting results. Reinsurers may provide coverage for a specific type of risk, such as catastrophe coverage, or may offer more general coverage.  

Key features of a reinsurer include:

  • Provides insurance coverage to other insurance companies (ceding companies) to help manage their risk
  • Helps ceding companies spread their risk and stabilize their underwriting results
  • May offer coverage for specific types of risk or more general coverage
  • Can help ceding companies free up capital and improve their financial strength
  • Assumes some or all of the risk associated with the policies that it reinsures
  • May also provide other services such as risk management or consulting.  

Example: Suppose a property and casualty insurance company writes a large number of policies covering homes in areas prone to hurricanes. The insurer may seek reinsurance coverage for hurricane-related losses from a reinsurer, which would agree to assume some of the risk associated with those policies. In return, the ceding company would pay the reinsurer a premium for this coverage. If a major hurricane were to hit the area and cause extensive damage, the ceding company would have some of its losses covered by the reinsurer, helping to limit its exposure and stabilize its financial results.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.